Information provided by the nominee

In February 2025, Diagnostyka, Poland’s leading laboratory diagnostics provider, debuted on the WSE, marking the 4th largest PE-backed IPO on the WSE in 5 years and one of Central Europe’s biggest PE exits ever. MidEuropa delivered an 11.5x MoM return, having successfully supported the Company’s buy-and-build strategy with 128 completed add-ons, creating a leading healthcare brand in Poland.